NFE2L2 and Hyperglycemia: Atorvastatin protects podocytes via the metastasis-associated lung adenocarcinoma transcript 1 (MALAT1)/miR-200c/nuclear factor-erythroid 2-related factor 2 (NRF2) signaling pathway from hyperglycemia (HG)-induced pyroptosis and oxidative stress [43].